Skip to main content
MedicHelpLine
Join Free
Verified Professional Network190+ CountriesHIPAA-Aware Platform
Back to Drug Index
General MedicationsINJECTIONGeneric

CYCLOSPORINE

CYCLOSPORINE

Standard Dose
50MG/ML
Max Dose
Refer to approved labeling
Primary Use
Marketing status: Discontinued
Summary

Approval overview CYCLOSPORINE is listed in Drugs@FDA under application 065151 (ANDA).

Marketing status: Discontinued Active ingredient CYCLOSPORINE Form and strength INJECTABLE;INJECTION - 50MG/ML Sponsor PADAGIS US Submission history Latest submission status date: 2015-06-30 00:00:00.

Structured Monograph

Clinical summary

Approval overview CYCLOSPORINE is listed in Drugs@FDA under application 065151 (ANDA). Marketing status: Discontinued Active ingredient CYCLOSPORINE Form and strength INJECTABLE;INJECTION - 50MG/ML Sponsor PADAGIS US Submission history Latest submission status date: 2015-06-30 00:00:00. Submission type: SUPPL.

Monitoring

  • • Review priority: STANDARD
  • • Marketing status: Discontinued

Interaction Notes

  • No interaction notes stored yet.